On 9 September, Dara Pharma took part in the latest edition of Bicor Day, the event organised by Bico Technologies in Guadalajara, Mexico, which brought together professionals from the pharmaceutical industry to share knowledge, analyse the latest technological trends and foster new opportunities for collaboration.
Having established itself as a leading meeting place for the sector, Bicor Day provides a forum for dialogue between manufacturers, technology suppliers and industry experts, promoting innovation and the development of solutions to address the current challenges facing pharmaceutical production.
As part of the event’s technical programme, the Dara Pharma team gave a presentation on the latest trends and challenges in the implementation of isolation technologies for aseptic processes, highlighting their vital role in ensuring product sterility, protecting operators and meeting the most stringent regulatory requirements.
In addition to the technical presentation, attendees had the opportunity to see first-hand some of the solutions developed by Dara Pharma for the manufacture of sterile products. Among these, an aseptic filling and sealing system for injectable vials was on display, as well as one of the company’s pilot freeze-dryers – solutions designed to deliver high levels of precision, efficiency and safety in pharmaceutical processes.
The event provided an opportunity to share experiences with clients and partners, address the challenges currently facing the industry, and gain first-hand insight into the trends driving the sector’s transformation in Mexico and Latin America.
For Dara Pharma, taking part in events such as Bicor Day represents an excellent opportunity to strengthen its ties with the market, promote the exchange of knowledge and continue to contribute to the advancement of technologies that improve the quality and safety of pharmaceutical manufacturing processes.
Dara Pharma would like to thank Bicor Technologies for organising this latest edition of Bicor Day, and all those who attended for the interest they showed in its solutions and technologies. The company remains committed to innovation as a driving force to support its clients in meeting the present and future challenges of the pharmaceutical industry.